Insider Buying Signals a Positive Outlook for Clorox

On September 23 2026, EVP‑Chief Legal Officer Hilt Angela C. added 11,436 shares of Clorox common stock to her portfolio, paying $83.94 per share – a modest $0.04 above the day’s close of $81.80. The purchase is part of a larger pattern of insider activity that includes simultaneous buys by the CEO, CFO, COO and other senior executives. With over 70 000 shares now held by Angela C., her stake has more than doubled since mid‑2025, reflecting confidence in the company’s long‑term trajectory.

Implications for Investors

The recent buy coincides with a slight uptick in Clorox’s share price (0.84 % weekly) and a bullish social‑media sentiment score of +12, amplified by a 66 % buzz index. While the market cap remains stable at $10.15 billion, the insiders’ buying spree signals that management believes the current valuation under‑prices future growth, particularly in the consumer‑staples segment that continues to resist macro‑economic headwinds. For investors, the move could be interpreted as a green light to hold or add positions, especially as the company maintains a solid dividend of $1.25 per share and a price‑earnings ratio of 17.44—well below the peer median in the household‑products space.

What the Trading Pattern Tells About Angela C.

Angela C.’s historical transactions illustrate a disciplined, long‑term investment philosophy. Between June 2025 and September 2026 she has executed six purchases totaling 50,000 shares, interspersed with modest sales that keep her holdings in the 30‑70 k share range. Her most recent transaction—11,436 shares at $83.94—falls within the price band she has consistently favored (between $82 and $95 over the past year). Unlike some insiders who trade opportunistically around earnings releases, Angela’s activity is largely uncorrelated with quarterly reports, suggesting a belief in Clorox’s core business model rather than short‑term catalysts.

Broader Insider Activity Context

The same day, the CEO and CFO added 50,988 and 11,913 shares respectively, while the COO added 13,342 shares. Across the executive team, a net buying position of roughly 120,000 shares was recorded. This collective confidence, coupled with Clorox’s robust dividend policy and its commitment to sustainability, creates a narrative of stability and incremental value creation that may appeal to value‑oriented investors.

Bottom Line

Clorox’s insider buying, spearheaded by Chief Legal Officer Angela C., underscores a belief in the company’s steady earnings stream and resilient consumer‑staples demand. For shareholders, the move is a signal that management sees upside in a stock trading near a 52‑week low, potentially offering a buying opportunity before the next cycle of price appreciation or dividend enhancement.

DateOwnerTransaction TypeSharesPrice per ShareSecurity
2026-09-23Hilt Angela C (EVP - Chief Legal Officer)Buy11,436.0083.94Common Stock
N/AHilt Angela C (EVP - Chief Legal Officer)Holding669.23N/ACommon Stock
2026-09-23Barton Nina (EVP-Chief Growth & Strategy Of)Buy10,721.0083.94Common Stock
2026-09-23Rendle Linda J (Chief Executive Officer)Buy50,988.0083.94Common Stock
2026-09-23Bellet Luc (EVP - Chief Financial Officer)Buy11,913.0083.94Common Stock
2026-09-23Hyder Chris T (EVP-Chief Operating Officer)Buy13,342.0083.94Common Stock
2026-09-23Marriner Kirsten (EVP - Chief Admin Officer)Buy12,389.0083.94Common Stock
2026-09-23Peck Laurene E (VP - CAO & Corp Controller)Buy2,192.0083.94Common Stock
N/APeck Laurene E (VP - CAO & Corp Controller)Holding100.00N/ACommon Stock